Edition:
India

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

5.50USD
9:39pm IST
Change (% chg)

$-0.35 (-5.98%)
Prev Close
$5.85
Open
$5.90
Day's High
$5.94
Day's Low
$5.50
Volume
12,042
Avg. Vol
13,769
52-wk High
$7.95
52-wk Low
$2.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.820
FY 2018 Dec '18 0.00 -0.380
Sep '18 0.00 -0.252
Jun '18 0.00 -0.454
Mar '18 0.00 -1.027
FY 2017 Dec '17 0.00 -0.625
Sep '17 0.00 -0.296
Jun '17 0.00 -0.288
Mar '17 0.00 -0.079
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 1 0.00 0.00 0.00 --
Quarter Ending Sep-19 1 0.00 0.00 0.00 --
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-19 3 -0.48 -0.31 -0.76 --
Quarter Ending Sep-19 3 -0.25 -0.21 -0.32 --
Year Ending Dec-19 3 -1.71 -1.46 -2.09 --
Year Ending Dec-20 3 -0.95 -0.68 -1.14 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.89 36.81
P/E High - Last 5 Yrs. -- 50.39 57.83
P/E Low - Last 5 Yrs. -- 27.47 28.52
Beta -- 0.96 0.95
Price to Sales (TTM) -- 8.14 10.07
Price to Book (MRQ) 4.82 3.76 4.41
Price to Tangible Book (MRQ) 4.82 4.06 5.24
Price to Cash Flow (TTM) -- 23.02 25.48
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.84 1.66
Dividend Yield - 5 Year Avg -- 1.47 1.34
Dividend 5 Year Growth Rate -- 6.31 6.45
Payout Ratio(TTM) -- 40.95 36.46

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 13.63 15.52
Sales (TTM) vs TTM 1 Yr. Ago -- 6.60 8.73
Sales - 5 Yr. Growth Rate -- 9.20 10.42
EPS (MRQ) vs Qtr. 1 Yr. Ago 20.19 18.33 19.01
EPS (TTM) vs TTM 1 Yr. Ago 14.74 -- --
EPS - 5 Yr. Growth Rate -- 5.51 7.17
Capital Spending - 5 Yr. Growth Rate -- 6.92 7.98

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.46 2.46
Current Ratio (MRQ) 3.16 3.44 3.41
LT Debt to Equity (MRQ) 0.00 13.40 14.32
Total Debt to Equity (MRQ) 0.00 18.65 20.12
Interest Coverage (TTM) -33.77 7.71 15.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.48 50.11
Gross Margin - 5 Yr. Avg. -- 50.46 51.30
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.40 16.09
Operating Margin (TTM) -- -3.15 -8.14
Operating Margin - 5 Yr. Avg. -- 13.64 11.31
Pre-Tax Margin (TTM) -- -3.67 -8.62
Pre-Tax Margin - 5 Yr. Avg. -- 19.70 16.08
Net Profit Margin (TTM) -- -7.34 -12.41
Net Profit Margin - 5 Yr. Avg. -- 14.80 11.25
Effective Tax Rate (TTM) -- 19.59 20.09
Effective Tax Rate - 5 Yr. Avg. -- 22.68 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 906,806,787 762,746,808
Net Income/Employee (TTM) -3,740,000 106,077,786 89,285,922
Receivable Turnover (TTM) -- 5.52 5.81
Inventory Turnover (TTM) -- 2.55 3.71
Asset Turnover (TTM) 0.00 0.84 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -99.65 9.96 9.60
Return on Assets - 5 Yr. Avg. -- 11.09 10.56
Return on Investment (TTM) -151.09 12.41 12.05
Return on Investment - 5 Yr. Avg. -- 14.12 13.45
Return on Equity (TTM) -151.09 13.73 16.96
Return on Equity - 5 Yr. Avg. -- 15.40 15.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -13.91 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Avenue Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.05%
# of Holders: 18
Total Shares Held: 1,166,819
3 Mo. Net Change: 471,166
# New Positions: 7
# Closed Positions: 0
# Increased Positions: 10
# Reduced Positions: 3
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.